Search

everythinglearnresearchcommunity

for

Search:↓

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

A genetic change in the EDAR gene causes the unique hair traits found in East Asians.

TNF family proteins are crucial for the development of skin features like hair, teeth, and mammary glands.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Certain hormone treatments can improve acne and related conditions in women.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Minoxidil effectively treats female pattern hair loss.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.